Scilex Holding Company Increase (Decrease) in Other Noncurrent Assets
Scilex Holding Company (SCLX) reported Increase (Decrease) in Other Noncurrent Assets of $994.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-14
- Scilex Holding Company increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $389.00K.
- Scilex Holding Company increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $605.00K.
- Scilex Holding Company increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $3.00K.
- Scilex Holding Company increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $0.00.
- Scilex Holding Company increase (decrease) in other noncurrent assets for fiscal 2025 was $3.00K, a 90.00% decline from fiscal 2024.
- Scilex Holding Company increase (decrease) in other noncurrent assets for fiscal 2024 was $30.00K.
- Scilex Holding Company increase (decrease) in other noncurrent assets for fiscal 2023 was -$855.00K.
- Scilex Holding Company increase (decrease) in other noncurrent assets for fiscal 2022 was -$350.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $389.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $994.00K 10-Q · filed 2026-08-14 | $997.00K derived: sum of 3 quarters · filed 2026-08-14 | $997.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $605.00K 10-Q · filed 2026-05-20 | $608.00K derived: sum of 2 quarters · filed 2026-05-20 | $608.00K derived: sum of 3 quarters · filed 2026-05-20 | $608.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $3.00K derived: sum of 2 quarters · filed 2026-04-10 | $3.00K derived: sum of 3 quarters · filed 2026-04-10 | $3.00K 10-K · filed 2026-04-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-20 | $0.00 derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-20 | $0.00 derived: sum of 2 quarters · filed 2026-05-20 | $0.00 derived: sum of 3 quarters · filed 2026-05-20 | $0.00 derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $0.00 derived: sum of 2 quarters · filed 2026-04-10 | $0.00 derived: sum of 3 quarters · filed 2026-04-10 | $30.00K 10-K · filed 2026-04-10 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $30.00K 10-Q · filed 2025-11-14 | -$21.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $30.00K 10-Q · filed 2025-08-13 | -$21.00K derived: sum of 3 quarters · filed 2025-08-13 | -$21.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $30.00K 10-Q · filed 2025-05-14 | -$21.00K derived: sum of 2 quarters · filed 2025-05-14 | -$21.00K derived: sum of 3 quarters · filed 2025-05-14 | $172.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$51.00K derived: sum of 2 quarters · filed 2025-03-31 | $142.00K derived: sum of 3 quarters · filed 2025-03-31 | -$855.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-17 | $193.00K derived: sum of 2 quarters · filed 2025-01-17 | -$804.00K 10-Q · filed 2025-01-17 | -$769.00K derived: sum of 4 quarters · filed 2025-01-17 |
| 2023-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$804.00K 10-Q · filed 2024-08-13 | -$769.00K derived: sum of 3 quarters · filed 2024-08-13 | -$1.07M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$997.00K 10-Q · filed 2024-05-13 | -$962.00K derived: sum of 2 quarters · filed 2024-05-13 | -$1.26M derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$264.00K derived: sum of 2 quarters · filed 2024-03-12 | -$350.00K 10-K · filed 2024-03-12 | |
| 2022-09-30 | -$299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$385.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$86.00K 10-Q · filed 2023-08-11 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-12 | |||
| 2020-12-31 | -$2.58M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |